VirusTotal for Threat Research: A Detailed Guide Released – 2024 CybersecurityNews

Novartis to Acquire Avidity for $12B, Bolstering Neuroscience Pipeline
Novartis said it is acquiring Avidity Biosciences for approximately $12 billion, the companies said Sunday, in a deal designed to bolster the buyer’s neuroscience pipeline
